1. Liu, Jinhui, Wang, Yuanyuan, Yin, Jian, Yu, Hao, Bai, Jianling. 2022. Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy. In Journal of oncology, 2022, 3477148. doi:10.1155/2022/3477148. https://pubmed.ncbi.nlm.nih.gov/35069733/
2. Wang, Xiaoyu, Lu, Xiansheng, Wang, Ping, Liang, Li, Lin, Jie. 2022. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner. In Journal of translational medicine, 20, 198. doi:10.1186/s12967-022-03399-3. https://pubmed.ncbi.nlm.nih.gov/35509101/
3. Luo, Chunyuan, He, Juan, Yang, Yang, Liu, Wenrong, Peng, Yong. 2024. SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. In Journal of cancer research and clinical oncology, 150, 292. doi:10.1007/s00432-024-05797-0. https://pubmed.ncbi.nlm.nih.gov/38842611/
4. Shanmugam, Raghuvaran, Zhang, Fan, Srinivasan, Harini, Meaney, Michael J, Tan, Meng How. . SRSF9 selectively represses ADAR2-mediated editing of brain-specific sites in primates. In Nucleic acids research, 46, 7379-7395. doi:10.1093/nar/gky615. https://pubmed.ncbi.nlm.nih.gov/29992293/
5. Bjorkman, Kristen K, Buvoli, Massimo, Pugach, Emily K, Polmear, Michael M, Leinwand, Leslie A. 2019. miR-1/206 downregulates splicing factor Srsf9 to promote C2C12 differentiation. In Skeletal muscle, 9, 31. doi:10.1186/s13395-019-0211-4. https://pubmed.ncbi.nlm.nih.gov/31791406/
6. Wang, Jing, Hu, Ming, Min, Jie, Li, Xin. 2024. A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer. In Cancer biology & therapy, 25, 2427415. doi:10.1080/15384047.2024.2427415. https://pubmed.ncbi.nlm.nih.gov/39530604/
7. Li, Zhiming, Liu, Xingping, Zhang, Yan, Zhou, Liquan, Yuan, Shuiqiao. 2024. FBXO24 modulates mRNA alternative splicing and MIWI degradation and is required for normal sperm formation and male fertility. In eLife, 12, . doi:10.7554/eLife.91666. https://pubmed.ncbi.nlm.nih.gov/38470475/
智鼠故事 
